SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000059478-23-000162
Filing Date
2023-04-27
Accepted
2023-04-27 11:56:56
Documents
70
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lly-20230331.htm   iXBRL 10-Q 2003005
2 EX-31.1 lly-03312023x10qxexhibit311.htm EX-31.1 10716
3 EX-31.2 lly-03312023x10qxexhibit312.htm EX-31.2 10722
4 EX-32 lly-03312023x10qxexhibit32.htm EX-32 7196
  Complete submission text file 0000059478-23-000162.txt   9507947

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20230331.xsd EX-101.SCH 47911
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20230331_cal.xml EX-101.CAL 68422
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20230331_def.xml EX-101.DEF 279987
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20230331_lab.xml EX-101.LAB 604397
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20230331_pre.xml EX-101.PRE 407832
64 EXTRACTED XBRL INSTANCE DOCUMENT lly-20230331_htm.xml XML 2188659
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 23853561
SIC: 2834 Pharmaceutical Preparations